To compare two drugs when used with a local anesthetic for upper limb surgeries

Comparative study between Tramadol and Butorphanol as an adjuvant to Bupivacaine for supraclavicular brachial plexus block.

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030500

Enrollment

Registered

2021-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M849- Disorder of continuity of bone, unspecified

Interventions

Intervention1: supraclavicular brachial plexus block: Two opioid adjuvants will be compared when added to a local anesthetic for supraclavicular block in upper limb orthopedic surgeries Intervention2:

Eligibility

Inclusion criteria

Inclusion criteria: ASA-PS I and II patients posted for upper limb orthopedic surgeries under Supraclavicular brachial plexus block.

Exclusion criteria

Exclusion criteria: Patient refusal, Morbidly obese patients (body mass index >35 kg/m2), Pregnant or lactating women, Allergy or addiction to study drugs, Patients receiving chronic analgesic therapy, Coagulopathies, and Pre-existing peripheral neuropathy

Design outcomes

Primary

Measure	Time frame
To study the onset and duration of sensory and motor blockade. Timepoint: 1.5 years	—

Secondary

Measure	Time frame
To study duration of postoperative analgesia, requirements of rescue analgesia, and drug-related adverse effects in Supraclavicular Brachial plexus block.Timepoint: 1.5 years	—

Countries

India

Contacts

Public ContactNiyati Garg

kalinga institue of medical sciences, bhubaneswar

ganesh.satapathy@kims.ac.in8283872939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026